We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Breast Ultrasound Combined with MRI Distinguishes Between Benign and Cancerous Lesions More Accurately

By MedImaging International staff writers
Posted on 10 Nov 2023
Print article
Image: Ultrasound combined with MRI is better able to identify cancerous lesions in breast tissue (Photo courtesy of 123RF)
Image: Ultrasound combined with MRI is better able to identify cancerous lesions in breast tissue (Photo courtesy of 123RF)

In breast imaging, nonmass-like lesions, which are areas in the breast with altered echotexture and no definitive shape, pose a diagnostic challenge. A new study has highlighted the potential of combining ultrasound and MRI to improve the differentiation between benign and malignant breast nonmass-like lesions.

The study by researchers at Chinese PLA General Hospital (Beijing, China) revealed that using ultrasound in conjunction with MRI is more effective in differentiating between benign and malignant lesions compared to using either method alone. This combined approach could lead to enhanced diagnostic accuracy. Both ultrasound and MRI have limitations that can result in incorrect identification of lesions, often leading to unnecessary biopsies. The research team explored the effectiveness of MRI in distinguishing between benign and malignant lesions after they were initially identified as nonmass-like by ultrasound. The hypothesis was that using two imaging techniques together might be more effective than one alone.

For the study, the researchers created a training dataset involving 180 patients with 183 nonmass-like lesions, comprising 88 benign and 95 malignant cases. Additionally, a validation dataset included 61 patients with 61 lesions, split between 30 benign and 31 malignant cases. The lesions were examined using MRI, ultrasound, and then a combination of both methods. In both datasets, the combined approach was effective in diagnosing cancer. In the training set, the combined method showed significant statistical improvement over MRI or ultrasound alone in terms of area under the curve (AUC) and specificity values. In the validation set, the combined method was superior to ultrasound alone but not to MRI alone.

The study found that malignant lesions had a significantly higher frequency of calcifications than benign lesions. Lesions with calcifications were found to be 5.6 times more likely to be malignant than those without, aligning with previous research indicating a high association of malignancy with hypo-echoic areas on ultrasound with calcifications. The combined method also identified two false-negative lesions, which were small and lacked typical malignant sonographic features, and correctly reclassified 11 false-positive lesions as benign. Pathology results were confirmed through surgical excision or biopsy.

“The integrated diagnostic strategy of US combined with MRI exhibited good performance for breast NMLs compared with either modality used alone, which can improve the diagnostic specificity while maintaining high sensitivity,” noted the researchers.

Related Links:
Chinese PLA General Hospital

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Doppler System
Doppler BT-200
Portable Radiology System
DRAGON ELITE & CLASSIC
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.